No Data
No Data
No Data
No Data
No Data
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
Yahoo FinanceMar 27 08:53 ET
Trending Stocks Today: Remark Holdings Gets a 11.2% Boost Post-Market
January 30th - US stocks trending post-market.Gainers: $Remark Holdings(MARK.US)$ gets a 11.2% boost to $1.39 with a turnover of $21.4 million. $Skyworks Solutions(SWKS.US)$ up 3.51% to $108 with a tu
moomoo NewsJan 30 16:55 ET
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
In its Q1 earnings release, Takeda Pharmaceutical Co Ltd (NYSE:TAK) said it agreed to discontinue further development of TAK-954 for post-operative gastrointestinal dysfunction and the parties' collaboration agreement with Theravance Biopharma Inc (NASDAQ:TBPH).
BenzingaMay 11, 2023 13:41 ET
Astellas Pharma, Eisai, Daiichi Sankyo and Takeda Join Hands to Reduce Environmental Burden in the Field of Pharmaceutical Packaging
Seeking AlphaDec 22, 2022 04:16 ET
After Six Years Of Collaboration, Takeda Walks Away From Microbiome Drug Pact
Finch Therapeutics Group Inc (NASDAQ:FNCH) will regain full development and commercial rights to FIN-524 (previously known as TAK-524) and FIN-525 from Takeda Pharmaceutical Company Ltd (NYSE:TAK). Fo
Benzinga Real-time NewsAug 26, 2022 07:38 ET
EXCLUSIVE: Takeda's Cancer Partner BridGene Raises $38.5M To Accelerate Work On Undruggable Targets
BridGene Biosciences Inc has completed a $38.5 million Series B financing by Lapam Capital, Junson Capital, and Dyee Capital. The platform enables screening small molecules against the whole proteome
Benzinga Real-time NewsJul 27, 2022 06:46 ET
No Data
No Data